Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with content, and download exclusive resources. Erik Steiger discusses the operational pain ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

Retrieval-augmented generation (RAG) has become the de facto standard for grounding large language models (LLMs) in private data. The standard architecture — chunking documents, embedding them into a ...

Google Cloud on Wednesday announced that its eighth generation of custom-built AI chips, or tensor processing units (TPUs), will be split in two. One chip, named the TPU 8t, will be geared for model ...

April 9 (Reuters) - Intel and Google have expanded their partnership to advance the use of artificial intelligence-focused central processing units and to develop custom infrastructure processors, as ...

CNBC got an exclusive first look at Arm's first ever in-house chip, the AGI CPU, purpose-built for running AI inference in data centers. Meta is the first official customer for the new chip, with ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

For decades, the West has been sleepwalking into dependency. While we built the world’s most advanced fighter jets, smartphones, and electric vehicles, we quietly surrendered the most important ...

Chevron’s flagship Gulf Coast refinery is processing its first Venezuelan oil shipment since the U.S. capture of Nicolás Maduro in Caracas last month, turning heavy, tar-like crude into gasoline, ...

To some, METR’s “time horizon plot” indicates that AI utopia—or apocalypse—is close at hand. The truth is more complicated. MIT Technology Review Explains: Let our writers untangle the complex, messy ...

Bioprocess developers have long known that the cell culture suite is where therapeutic proteins earn—or lose—their quality. Subtle shifts in raw materials, cell line genetics, or control ranges can ...